Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Nati Harnik/AP

Obamacare didn't kill the health insurance industry, and whatever comes after won't kill it either — as long as it can scrape through the next few years.

There's been a lot of nervous talk from insurance CEOs about how they need to know what's happening next. That's a real problem, as Republicans struggle to figure out what they're actually going to do about Obamacare. But the bigger picture looks much better.

Wall Street analysts are betting health insurers — who have mostly thrived under Obamacare despite their recent setbacks — will become even stronger under Donald Trump and Republicans, who plan to shred regulations and push more taxpayer-funded programs into private control.

What's at stake: Roughly 10.4 million people bought coverage through Obamacare's exchanges and kept it in 2016. It's unclear how that number will change based on the 2017 open enrollment, which just ended last week. While Aetna, Humana, UnitedHealth Group and some other insurers have abandoned the marketplaces, Blue Cross Blue Shield plans, Medicaid-based plans and not-for-profits still have sizable interests.

What's next: Republicans have signaled they will repeal the law immediately and replace it with something else down the road. But without critical details, like how they'll get enough healthy customers without the individual mandate, even the most committed insurers have little incentive to remain in a marketplace that could implode from lower enrollment or a worse risk pool. Anthem and Molina, for example, have already started hedging their commitments.

Companies need to know a replacement timeline soon, since they have to file 2018 Obamacare plans by the spring and will prepare for 2019 soon after.

"There has to be a pretty long runway to what the next system is going to be," said Ceci Connolly, CEO of the Alliance of Community Health Plans, which represents large provider-based insurers like Kaiser Permanente and UPMC.

She said the industry is pushing for at least a three-year transition period. Anything less could drive insurers away. One sign of nervousness: Companies are already reviewing state laws to see what it would take to exit if, for example, Obamacare's cost-sharing subsidies are revoked.

"It would be irresponsible to not understand what options are available," Connolly said.

Congress can persuade insurers to stay in the exchanges with a couple enticements:

  • Loosening regulatory requirements, especially around benefits. Paring back Obamacare's required benefits has been a rallying cry for almost all insurers, but consumer advocates worry that could bring back the days of exhaustive medical underwriting and junk insurance. "There's an extreme you wouldn't want to go to, but we need to see a relaxation," said Dr. John Bennett, CEO of CDPHP, a not-for-profit health insurer in New York.
  • Paying out risk corridors. Insurers selling in the exchanges are still owed more than $8 billion in risk-corridor payments — one of the ways they were supposed to be compensated for covering a lot of expensive people. Depending how Congress acts, that money may go unpaid.

Republicans have derided Obamacare's temporary risk corridors as government "bailouts," even though the same program exists in Medicare Part D. But that funding could help insurers stay and prevent a marketplace collapse if Congress delays an Obamacare replacement.

Highmark, the Blue Cross Blue Shield plan based in Pittsburgh that is suing the feds over unpaid risk corridors, is encouraging the government to "live up to its financial commitments." Republicans could dress up the money with a different name or through state-based funds, Connolly said.

The big picture still looks good. For all the political attention the Obamacare exchanges receive, that market represents just a sliver of the money insurers handle. Financial analysts are bullish toward insurers because other business segments don't face the same kind of crippling uncertainty as the exchanges.

  • Coverage from big employers. Even if Republicans pass their own version of Obamacare's "Cadillac tax" on generous benefit plans — a stretch given wide opposition from employers and unions — the main change to coverage will be the continued cost shift to workers. That's a positive for insurers, but it could inflame the populist outrage over out-of-pocket costs.
  • Medicare Advantage. The private program enrolls a third of Medicare enrollees and offers a stable profit for plans that can boost membership and code medical diagnoses aggressively. Both parties now heavily defend Medicare Advantage because of its rising popularity among seniors. Insurers expect Congress and the Trump administration to shovel incentives the program's way.
  • Medicaid managed care. Virginia, for example, recently announced that Aetna, UnitedHealth and five other companies won a contract for the state's $3.5 billion program that manages Medicaid's long-term care. It's worth noting, however, that insurers aren't fans of block grants, which would cut revenue and complicate contracts.

Go deeper

Dan Primack, author of Pro Rata
3 hours ago - Economy & Business

FTX CEO predicts more U.S. crypto flight

Photo: "Axios on HBO"

FTX doesn't look much like a company valued at $25 billion. Its new headquarters, located in a sleepy part of The Bahamas, is so nondescript as to not even have a sign. But it does expect to soon have neighbors.

Driving the news: Founder and CEO Sam Bankman-Fried tells "Axios on HBO" to expect "more and more crypto flight from the states" if the U.S. doesn't soon create a regulatory regime for cryptocurrencies.

Developed countries reveal $100 billion climate finance plan ahead of COP26

Alok Sharma, head of the UN Climate Summit in Glasgow, speaks in Paris on Oct. 12. ( Li Yang/China News Service via Getty Images)

After 12 years of fits and starts, industrialized nations on Monday put forward a detailed plan to provide at least $100 billion annually in climate aid to developing countries starting by 2023.

Why it matters: The plan, presented by representatives of Canada and Germany, is aimed at defusing one of the biggest sources of tension at COP26, which is the failure of industrialized nations to follow through on their financial commitments.

4 hours ago - Health

Moderna says COVID vaccine shows strong immune response in kids

Photo: Martin Galindo/Long Visual Press/Universal Images Group via Getty Images

Moderna on Monday released trial results for its coronavirus vaccine for children aged 6 to 11, saying it provides a "robust" immune response after two doses.

Why it matters: Moderna said it will officially submit the results to the Food and Drug Administration for authorization in "the near term," meaning we could soon see two coronavirus vaccines available to protect approximately 28 million more kids in the U.S.